XBiotech Inc

XBiotech Inc. is a privately held company based in Austin, Texas, with a team of 98 employees. Founded with the mission of advancing therapeutic antibody research, XBiotech has emerged as a global leader in the field of biosciences. The company specializes in the discovery, development, and commercialization of therapeutic antibodies leveraging its proprietary True Human™ technology. Unlike traditional antibody therapies, XBiotech's True Human™ antibodies are 100 percent human, derived from individuals with natural immunity to specific diseases. This innovative approach holds the potential to improve the safety, efficacy, and tolerability of antibody therapies across a range of diseases. XBiotech's focus areas include oncology, inflammatory conditions, and infectious diseases. Its extensive pipeline of True Human™ antibodies is designed to surpass current treatment standards by harnessing the body's natural immune response. These antibodies are cloned directly from donors with natural immunity, preserving their natural physiology and tolerance profile. For more information about XBiotech Inc. and its groundbreaking research, please visit their website at xbiotech.com.